| Financial Year |
March 31 2023 |
| Monetary Funds |
609,646,889.27 |
| Held-for-trading Financial Assets |
1,916,848.62 |
| Notes Receivable |
8,310,928.22 |
| Accounts Receivable |
584,946,934.63 |
| Advances to Suppliers |
16,665,250.61 |
| Other Receivables |
9,999,816.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
366,650,596.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,207,295.63 |
| Total Current Assets |
1,647,875,224.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,428,447.14 |
| Investment Properties |
33,544,654.56 |
| Fixed Assetes |
345,265,375.59 |
| Under-construction Projects |
50,891,349.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,242,193.81 |
| R&D expenses |
-- |
| Goodwill |
13,305.85 |
| Long-Term Deferred and Prepaid Expenses |
8,026,536.86 |
| Deferred Income Tax Assets |
42,156,698.90 |
| Other Non-Current Assets |
13,844,593.40 |
| Sub-Total of Non-Current Assets |
583,542,857.19 |
| Total Assets |
2,231,418,082.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
213,816,603.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,549,149.29 |
| Taxes Payable |
49,479,093.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,855,697.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,292,659.58 |
| Other Current Liabilities |
1,034,720.53 |
| Sub-Total of Current Liabilities |
473,065,289.90 |
| Long-term Loans |
7,494.81 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,379,251.13 |
| Deferred Income Tax Liabilities |
6,203,241.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,152,543.65 |
| Total Liabilities |
506,217,833.55 |
| Paid-In Capital(Or Share Stock) |
513,393,236.00 |
| Capital Surplus |
64,521,318.58 |
| Surplus Reserve |
28,206,442.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
965,202,885.85 |
| Minority Stockholder's Interest |
133,210,944.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,591,989,303.98 |
| Owner's Equity（Stockholder's Equity） |
1,725,200,248.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,231,418,082.18 |
